The CMS Changes Coming To Medicare Part D Market

By Margaux Hall and Stephanie Webster (May 17, 2022, 4:37 PM EDT) -- On April 29, the Centers for Medicare & Medicaid Services issued a final rule revising the way Medicare determines the negotiated price — i.e., the price upon which beneficiary cost sharing is based at the pharmacy counter — under Medicare Part D.[1]

The 2022 final rule revises the definition of "negotiated price" to mean the lowest possible reimbursement a network pharmacy will receive in total for a covered Part D drug.[2] The final rule adopts this new definition of negotiated price across Part D, including the Medicare Coverage Gap Discount Program.

The final rule could likely have several effects on the Medicare...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!